Global analysis of protein activities using proteome chips

• US 20050182242A1
• Filed: 05/13/2002
• Published: 08/18/2005
• Est. Priority Date: 05/11/2001
• Status: Abandoned Application

• Current Assignee: Yale University
• Original Assignee: Yale University
• Inventors: Jansen, Ronald, Casamayor, Antonio, Bertone, Paul, Gerstein, Mark, Bilgin, Metin, Lan, Ning, Zhu, HengZhu, Bidlingmaier, Scott M., Snyder, Michael
• Application Number:
  US10/477,329
• Publication Number:
  US 20050182242A1
• Time in Patent Office: Days
• US Class Current: 530/350
• CPC Class Codes: C07K 1/047 Simultaneous synthesis of different peptide species; Peptide libraries
• CPC Class Codes: C07K 1/1077 by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C40B 30/04 by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
• CPC Class Codes: G01N 33/6818 Sequencing of polypeptides
• CPC Class Codes: G01N 33/6842 Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
• CPC Class Codes: G01N 33/6845 Methods of identifying protein-protein interactions in protein mixtures
• CPC Class Codes: G01N 33/92 involving lipids, e.g. cholesterol , lipoproteins, or their receptors steroid hormones G01N33/743

Abstract

The present invention relates to proteome chips comprising arrays having a large proportion of all proteins expressed in a single species. The invention also relates to methods for making proteome chips. The invention also relates to methods for using proteome chips to systematically assay all protein interactions in a species in a high-throughput manner. The present invention also relates to methods for making and purifying eukaryotic proteins in a high-density array format. The invention also relates to methods for making protein arrays by attaching double-tagged fusion proteins to a solid support. The invention also relates to a method for identifying whether a signal is positive.

Claims

1. A positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins comprises at least one protein encoded by at least 50% of the known genes in a single species.

2. The array of claim 1, wherein the plurality of proteins comprises at least one protein encoded by at least 70% of the known genes in a single species.

6. The array of claim 1, 3, 4, or 5, wherein the proteins are organized on the array according to a classification of proteins.

7. The array of claim 6, wherein the classification is by abundance, function, enzymatic activity, homology, protein family, association with a particular metabolic pathway, or posttranslational modification.

8. The array of claim 1, 3, 4, or 5, wherein the proteins are attached to the solid support via a His tag.

9. The array of claim 1, 3, 4, or 5, wherein the solid support comprises nickel.

10. The array of claim 1, 3, 4, or 5, wherein the solid support comprises a nickel-coated slide.

77. The array of claim 1, 3, 4, or 5, wherein the proteins are attached to the solid support via a biotin tag.

80. The array of claim 1, 3, 4, or 5, wherein the solid support comprises a nitrocellulose-coated slide.

3. A positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins comprises at least 50% of all proteins expressed in a single species, wherein protein isoforms and splice variants are counted as a single protein.

4. A positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins comprises at least 1000 proteins expressed in a single species.

5. A positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins in aggregate comprise proteins encoded by at least 1000 different known genes in a single species.

11. A method for making a positionally addressable array comprising the step of attaching a plurality of proteins to a surface of a solid support, with each protein being at a different position on the solid support, wherein the plurality of proteins comprises at least one protein encoded by at least 50% of the known genes in a single species.

12. A method for making a positionally addressable array comprising the step of attaching a plurality of proteins to a surface of a solid support, with each protein being at a different position on the solid support, wherein the plurality of proteins comprises at least 50% of all proteins expressed in a single species, wherein protein isoforms and splice variants are counted as a single protein.

13. A method for making a positionally addressable array comprising the step of attaching a plurality of proteins to a surface of a solid support, with each protein being at a different position on the solid support, wherein the plurality of proteins comprises at least 1000 proteins expressed in a single species.

14. A method for making a positionally addressable array comprising the step of attaching a plurality of proteins to a surface of a solid support, with each protein being at a different position on the solid support, wherein the plurality of proteins in aggregate comprise proteins encoded by at least 1000 different known genes in a single species.

15. A method for making a positionally addressable array comprising the step of attaching a plurality of fusion proteins to a surface of a solid support, with each fusion protein being at a different position on the solid support, wherein the fusion protein comprises a first tag, a second tag, and a protein sequence encoded by genomic nucleic acid of an organism.

16. The method of claim 15, wherein prior to said attaching step is a step of purifying the protein by contacting the protein with the binding partner of the said first tag, and wherein the second tag is used in said attaching step to attach the protein to the solid support.

17. The method of claim 16, wherein the first tag is a GST tag and the second tag is a His tag.

18. The method of claim 15, wherein the first tag and the second tag are found at the amino-terminal end of the protein.

19. The method of claim 15, wherein the first tag and the second tag are found at the carboxy-terminal end of the protein.

78. The method of claim 15, wherein the first tag is found at the carboxy-terminal end of the protein and the second tag is found at the amino-terminal end of the protein.

20. A method for making and isolating a plurality of purified protein samples, comprising the steps of:

at each site of a plurality of sites of a multi-site array;

(a) growing a eukaryotic cell having a heterologous nucleotide sequence operatively linked to a regulatory sequence;

(b) contacting the regulatory sequence with an inducer that enhances expression of a protein encoded by the heterologous nucleotide sequence;

(c) lysing the cell to produce a cell lysate;

(d) contacting the cell lysate or protein-containing sample therefrom with a binding agent such that a complex between said protein and binding agent is formed; and

(e) isolating the protein from the complex;

wherein each step is conducted in a multi-array format.

21. The method of claim 20, wherein each site is a well.

22. The method of claim 20, wherein said protein is a fusion protein comprising an affinity tag to which said binding agent binds.

23. The method of claim 20, wherein the cell is a yeast cell.

24. The method of claim 20, wherein said lysing step is performed using a paint shaker.

72. The method of claim 20, wherein the multi-site array is a 96-site array.

79. The method of claim 22, wherein the affinity tag is biotin.

25. A method for detecting a lipid-binding protein comprising the steps of:

(a) contacting a probe comprising a lipid with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support; and

(b) detecting any protein-probe interaction, wherein detection of the interaction at a position on the solid support indicates the presence of a lipid-binding protein at said position.

26. The method of claim 25, wherein the lipid is a phospholipid.

27. The method of claim 26, wherein the phospholipid is phosphatidylcholine or phosphatidylinositol.

28. The method of claim 25, wherein the probe comprises a liposome.

44. The method of claim 25, 29, 30, 31, 32, or 33, wherein the probe is from a mammal.

45. The method of claim 44, wherein the mammal is human.

46. The method of claim 44, wherein the plurality of proteins is non-human.

47. The method of claim 25, 29, 30, 31, 32, or 33, wherein the plurality of proteins is attached to the solid support via a His tag.

48. The method of claim 25, 29, 30, 31, 32, or 33, wherein the solid support comprises nickel.

49. The method of claim 25, 29, 30, 31, 32, or 33, wherein the solid support comprises a nickel-coated slide.

29. A method for detecting a binding protein comprising the steps of:

(a) contacting a probe with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins comprises at least one protein encoded by at least 50% of the known genes in a single species; and

(b) detecting any protein-probe interaction.

34. The method of claim 29, 30, 31, 32, or 33, wherein the probe comprises a nucleic acid, protein, small molecule, drug candidate or lipid.

35. The method of claim 34, wherein the nucleic acid comprises RNA or DNA.

36. The method of claim 34, wherein the probe is a yeast protein.

37. The method of claim 36, wherein the yeast protein is Myo2, Rho1, Rho2, Rho3, Rho4, Cdc11, Cdc12, or Hs17.

38. The method of claim 34, wherein the probe is an antibody.

39. The method of claim 38, wherein the antibody is directed against cyclin, kinase, GST, Clb5, Cla4, Ste20, Cdc42, PI(3,4)P2, PI(4)P, SPA2, CLB1, CLB2, or Cdc11.

40. The method of claim 34, wherein the probe is calmodulin.

41. The method of claim 34, wherein the probe comprises a small molecule selected from the group consisting of ATP, GTP, cAMP, phosphotyrosine, phosphoserine, and phosphothreonine.

42. The method of claim 34, wherein the probe comprises phosphatidylcholine or phosphatidylinositol.

43. The method of claim 34, wherein the probe comprises a liposome.

50. The method of claim 34, further comprising the step of determining the identity of a probe whose interaction with a protein is detected in said detecting step.

51. The method of claim 50, wherein said interaction indicates that said identified probe is an antibacterial, antifungal, or antiviral protein.

30. A method for detecting a binding protein comprising the steps of:

(a) contacting a probe with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins comprises at least 50% of all proteins expressed in a single species, wherein protein isoforms and splice variants are counted as a single protein; and

(b) detecting any protein-probe interaction.

31. A method for detecting a binding protein comprising the steps of:

(a) contacting a probe with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins comprises at least 1000 proteins expressed in a single species; and

(b) detecting any protein-probe interaction.

32. A method for detecting a binding protein comprising the steps of:

(a) contacting a probe with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins in aggregate comprise proteins encoded by at least 1000 different known genes in a single species; and

(b) detecting any protein-probe interaction.

33. A method for detecting a binding protein comprising the steps of:

(a) contacting a probe with a positionally addressable array comprising a plurality of fusion proteins, with each fusion protein being at a different position on a solid support, wherein the fusion protein comprises a first tag, a second tag, and a protein sequence encoded by genomic nucleic acid of an organism; and

(b) detecting any protein-probe interaction.

52. A method of labeling a protein for use in a binding assay, comprising the steps of:

(a) contacting separate aliquots of said protein with a biotin-transferring compound under conditions and for a period of time to produce said proteins that are biotinylated to differing degrees among the different aliquots; and

(b) combining together said different aliquots to produce a sample of differentially biotinylated protein.

53. A method for detecting a binding protein comprising the steps of:

(a) contacting a sample of biotinylated protein produced by the method of claim 52 with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support; and

(b) detecting any positions on the array, wherein interaction between a biotinylated protein and a protein on the array occurs.

54. A method for detecting a binding protein comprising the steps of:

(a) contacting a sample of biotinylated protein produced by the method of claim 52 with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support;

(b) contacting said array with streptavidin conjugated to a fluor; and

(c) detecting any positions on the array at which fluorescence occurs, wherein said fluorescence indicates that interaction between a biotinylated protein and a protein on the array occurs.

55. A method for determining whether a protein preferentially binds phosphatidylinositol as compared with phosphatidylcholine, comprising the steps of:

(a) contacting a probe comprising phosphatidylinositol with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support;

(b) detecting protein-probe interaction, wherein said interaction at a position on the solid support indicates the presence of a phosphatidylinositol-binding protein;

(c) contacting a probe comprising phosphatidylcholine with a positionally addressable array comprising a plurality of proteins, said proteins comprising at least some of the same proteins as in step (a), with each protein being at a different position on a solid support;

(d) detecting protein-probe interaction, wherein the interaction at a position on the solid support indicates the presence of a phosphatidylcholine-binding protein; and

(e) comparing, for each of a plurality of proteins, the results of steps (b) and (d).

56. A method for determining if a phospholipid regulates a metabolic pathway or signal transduction pathway in a cell, or if said metabolic or signal transduction pathway occurs on membrane surfaces, comprising the steps of:

(a) contacting a probe comprising phospholipid with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support, wherein the plurality of proteins comprise one or more proteins that form at least part of said pathway; and

(b) detecting interaction of said probe with a protein in said pathway;

wherein said interaction indicates that said probe regulates said metabolic pathway or signal transduction pathway, or that said pathway occurs on membrane surfaces.

57. A method for making a non-naturally occurring protein that binds calmodulin comprising making a non-naturally occurring protein comprising the following sequence:

I/L-Q-X—

X—

K—

K/X-G-B  

 

(SEQ ID NO;

     1)

wherein X is any amino acid and B is a basic amino acid.

58. A method for determining the presence or absence of a posttranslational modification in a protein comprising the steps of:

(a) contacting a probe that binds to said posttranslational modification with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support; and

(b) detecting any interaction of said probe with a protein;

wherein said interaction at a position on the solid support indicates that the protein at said position has said posttranslational modification.

59. The method of claim 58, wherein said posttranslational modification is methylation, phosphorylation, biotinylation, acetylation, pegylation, glycosylation, lipid modification, ubiquitination, and sumolation.

60. A method for preparing a culture of yeast cells, comprising the steps of:

(a) growing a plurality of yeast cells in a growth medium until the OD₆₀₀ is between 0.3 and 1.0, wherein said plurality of yeast cells comprises a heterologous nucleotide sequence operatively linked to a regulatory sequence,

(b) contacting said cell with an inducer that enhances expression of a protein encoded by said heterologous nucleotide sequence;

(c) separating said cells from said medium;

(d) contacting said cells with cold water;

(e) separating said cells from said cold water;

(f) contacting said cells with cold lysis buffer;

(g) separating said cells from said lysis buffer; and

(h) freezing said cells semi-dry for storage.

61. A method for purifying a protein from a cell, comprising the steps of:

(a) for each of a plurality of cell samples, lysing cells in each of said sample to produce a cell lysate, wherein said cell comprises a fusion protein having an affinity tag, and wherein said lysing step is performed using a paint shaker;

(b) separating each said lysate into a soluble fraction and a non-soluble fraction;

(c) transferring each said soluble fraction into a different site of a multi-site array, wherein said transferring step is performed using a wide-open tip;

(d) contacting each said soluble fraction with a binding agent such that a complex between said fusion protein and binding agent is formed;

(e) isolating each said fusion protein from the complex; and

(f) storing each said fusion protein in a buffer of high viscosity.

62. A method for identifying whether a signal is positive, comprising the steps of:

(a) determining foreground and background signals for each spot locally and determining net signals from the difference between said foreground and background signals;

(b) determining the lower quartile, median, and upper quartile values of a first and second net signal distribution;

(c) subtracting a first median value from said first net signal distribution, and subtracting a second median value from said second net signal distribution to obtain a first and second subtracted value, respectively;

(d) dividing said first subtracted value by the difference between said upper and lower quartile values of said first signal distribution, and dividing said second scaled value by the difference between said upper and lower quartile values to obtain a first and second scaled value, respectively;

(e) determining a local median value of a scaled signal distribution of a neighborhood region, wherein said neighborhood region comprises a plurality of sites in the area; and

(f) subtracting the local median value from the scaled signal to obtain a scaled excess value.

63. The method of claim 62, wherein a positive signal indicates protein-probe interaction.

64. The method of claim 62, wherein the neighborhood region is two rows above, two rows below, two columns to the left, and two columns to the right of the signal.

65. The method of claim 62, further comprising the step of excluding parallel samples of scaled excess values if the difference between one of the sample values and the average of the sample values is greater than three standard deviations of the error of the scaled excess value.

74. The method of claim 62 or 65, further comprising the steps of:

(a) averaging the values of the signals of two duplicate spots to obtain an average value; and

(b) determining whether said average value is greater than three standard deviations of the error of the scaled excess value,

wherein a signal of said spot is positive if said average value is greater than three standard deviations of the error of the scaled excess value.

66. A method for identifying positive signals among signals measured with a plurality of different arrays, comprising the steps of:

(a) transforming signals measured with different arrays to generate transformed signals;

(b) correcting each said transformed signal by a method comprising subtracting from said transformed signal a local median signal to generate a corrected transformed signal, wherein said local median signal is the median of signals in a neighborhood region, said neighborhood region comprising one or more sites around site of said transformed signal; and

(c) comparing said each said corrected transformed signal to a threshold value, and identifying said corrected transformed signal as positive if said corrected transformed signal is greater than said threshold value;

wherein said array comprises a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support.

67. The method of claim 66, wherein said step of transforming comprises the steps of:

(a) determining for signals measured with each of said different arrays the lower quartile value, the median value, and the upper quartile value of the signal distribution;

(b) subtracting from signals measured with each of said different arrays said median value to obtain translated signals for said array; and

(c) dividing said translated signals by the difference between said upper and lower quartile values of said array, thereby generating said transformed signals.

68. The method of claim 66, wherein said neighborhood region consists of sites within an area two rows above, two rows below, two columns to the left, and two columns to the right of the transformed signal.

69. The method of claim 66, 67, or 68, wherein said positive signal indicates protein-probe interaction.

70. The method of claim 66, 67, or 68, further comprising the step of discarding data points, wherein said data points are measured at duplicate sites on the array;

and wherein the variation between said duplicate sites is greater than three standard deviations.

71. The method of claim 66, 67, or 68, further comprising the step of normalizing the corrected transformed signals using the formula:

73. A method for making a positionally addressable array comprising the step of attaching a plurality of fusion proteins to a surface of a solid support, with each fusion protein being at a different position on the solid support, wherein the fusion protein comprises a first tag, a second tag, and a protein sequence encoded by genomic nucleic acid of an organism.

75. A method for determining the presence or absence of an enzymatic activity in a protein comprising the steps of:

(a) contacting a probe that is a substrate for said enzymatic activity with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support; and

(b) detecting any catalysis of said substrate at a position on the solid support;

wherein said catalysis at a position on the solid support indicates that the protein at said position has said enzymatic activity.

76. A method for determining the presence or absence of an enzyme substrate in a protein comprising the steps of:

(a) contacting a probe that is an enzyme for said enzyme substrate with a positionally addressable array comprising a plurality of proteins, with each protein being at a different position on a solid support; and

(b) detecting any catalysis of said substrate at a position on the solid support;

wherein said catalysis at a position on the solid support indicates that the protein comprises said enzyme substrate.